Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Immunogenic properties of plant-derived recombinant smallpox vaccine candidate pB5.

Portocarrero C, Markley K, Koprowski H, Spitsin S, Golovkin M.

Vaccine. 2008 Oct 9;26(43):5535-40. doi: 10.1016/j.vaccine.2008.07.063. Epub 2008 Aug 14.

PMID:
18706953
2.

Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.

Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.

Virology. 2008 Oct 25;380(2):412-20. doi: 10.1016/j.virol.2008.08.002. Epub 2008 Sep 10.

3.

A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.

Hotomi M, Ikeda Y, Suzumoto M, Yamauchi K, Green BA, Zlotnick G, Billal DS, Shimada J, Fujihara K, Yamanaka N.

Vaccine. 2005 Jan 26;23(10):1294-300.

PMID:
15652672
4.

A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques.

Egan MA, Chong SY, Hagen M, Megati S, Schadeck EB, Piacente P, Ma BJ, Montefiori DC, Haynes BF, Israel ZR, Eldridge JH, Staats HF.

Vaccine. 2004 Sep 9;22(27-28):3774-88.

PMID:
15315859
5.

Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.

Patel GB, Zhou H, Ponce A, Chen W.

Vaccine. 2007 Dec 12;25(51):8622-36. Epub 2007 Oct 5.

PMID:
17959279
6.

Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine.

Isaka M, Komiya T, Takahashi M, Yasuda Y, Taniguchi T, Zhao Y, Matano K, Matsui H, Maeyama J, Morokuma K, Ohkuma K, Goto N, Tochikubo K.

Vaccine. 2004 Aug 13;22(23-24):3061-8.

PMID:
15297056
7.

Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.

Parez N, Fourgeux C, Mohamed A, Dubuquoy C, Pillot M, Dehee A, Charpilienne A, Poncet D, Schwartz-Cornil I, Garbarg-Chenon A.

J Virol. 2006 Feb;80(4):1752-61.

8.

Immunogenic properties of the Salmonella atypical fimbriae in BALB/c mice.

Strindelius L, Folkesson A, Normark S, Sjöholm I.

Vaccine. 2004 Mar 29;22(11-12):1448-56.

PMID:
15063568
9.
11.

Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA.

Ciabattini A, Giomarelli B, Parigi R, Chiavolini D, Pettini E, Aricò B, Giuliani MM, Santini L, Medaglini D, Pozzi G.

Vaccine. 2008 Aug 5;26(33):4244-50. doi: 10.1016/j.vaccine.2008.05.049. Epub 2008 Jun 6.

PMID:
18582996
12.

Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.

Bessa J, Schmitz N, Hinton HJ, Schwarz K, Jegerlehner A, Bachmann MF.

Eur J Immunol. 2008 Jan;38(1):114-26.

13.
14.

Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.

Berhanu A, Wilson RL, Kirkwood-Watts DL, King DS, Warren TK, Lund SA, Brown LL, Krupkin AK, Vandermay E, Weimers W, Honeychurch KM, Grosenbach DW, Jones KF, Hruby DE.

J Virol. 2008 Apr;82(7):3517-29. doi: 10.1128/JVI.01854-07. Epub 2008 Jan 16.

15.
16.

Smallpox subunit vaccine produced in Planta confers protection in mice.

Golovkin M, Spitsin S, Andrianov V, Smirnov Y, Xiao Y, Pogrebnyak N, Markley K, Brodzik R, Gleba Y, Isaacs SN, Koprowski H.

Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6864-9. Epub 2007 Apr 11.

17.

Bordetella pertussis can act as adjuvant as well as inhibitor of immune responses to non-replicating nasal vaccines.

Haugan A, Thi Dao PX, Glende N, Bakke H, Haugen IL, Janakova L, Berstad AK, Holst J, Haneberg B.

Vaccine. 2003 Dec 8;22(1):7-14.

PMID:
14604565
18.

Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.

Isaka M, Zhao Y, Nobusawa E, Nakajima S, Nakajima K, Yasuda Y, Matsui H, Hasegawa T, Maeyama J, Morokuma K, Ohkuma K, Tochikubo K.

Microbiol Immunol. 2008 Feb;52(2):55-63. doi: 10.1111/j.1348-0421.2008.00010.x.

19.

Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.

Takahashi Y, Kumada H, Hamada N, Haishima Y, Ozono S, Isaka M, Yasuda Y, Tochikubo K, Umemoto T.

Oral Microbiol Immunol. 2007 Dec;22(6):374-80.

PMID:
17949339
20.

Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate.

Matoba N, Geyer BC, Kilbourne J, Alfsen A, Bomsel M, Mor TS.

Vaccine. 2006 Jun 5;24(23):5047-55. Epub 2006 Mar 30.

PMID:
16621185

Supplemental Content

Support Center